Table 1.
Type of Research | Bioactive Component | Source/Origin | Model System | Main Findings | Study |
---|---|---|---|---|---|
Animal | Levan | Bacillus licheniformis | Wistar rats induced T1D with alloxan (150 mg/kg BW) | ↓Glycaemia, ↑glycogen level, ↓AST, ALT, bilirubin, creatinine, and urea levels | Dahech et al., 2011 [83] |
Levan | Bacillus subtilis (Natto) | Wistar rats induced T1D with STZ (65 mg/kg BW) | No hypoglycaemic effect. No improvement of diabetes symptoms | Bazani et al., 2012 [88] | |
Exopolysaccharide (unspecified) | Bacillus subtilis | Sprague-Dawley rats induced T1D with STZ (65 mg/kg BW) | ↓FBG, ↑serum insulin levels, ↓TC, LDL, VLDL and TG, ↑HDL in treated vs. control rats | Ghoneim et al., 2016 [89] | |
Selenium-enriched exopolysaccharide | Enterobacter cloacaceae Z0206 | Female ICR mice induced T1D with alloxan (190 mg/kg) | ↓FBG, ↑serum insulin level, ↓glycosylated serum protein, ↑BW, ↓TC and TG in treated vs. control mice | Jin et al., 2012 [26] | |
Exopolysaccharide (unspecified) | Sorangium cellulosum NUST06 | Mice (Kunming strain) induced T1D with alloxan (250 mL/kg BW) | ↓FBG in both healthy and alloxan-induced diabetic mice | Ding et al., 2004 [91] | |
Cell line | Exopolysaccharide (unspecified) | Lactobacillus plantarum H31-2 | In vitro, insulin-resistant HepG2 cells | ↓Supernatant glucose concentration of insulin-resistant HepG2 cells, inhibition of pancreas α-amylase, upregulation of the expression of GLUT-4, Akt-2, and AMPK | Huang et al., 2020 [90] |
ALT: alanine aminotransferase; AST: aspartate aminotransferase; BW: body weight; FBG: fasting blood glucose; ICR: Institute Cancer Research; HDL: high-density lipoprotein; LDL: low-density lipoprotein; STZ: streptozotocin; TC: total cholesterol; TG: triglyceride; T1D: type 1 diabetes; VLDL: very-low-density lipoprotein. ↑ means increase, ↓ means decrease.